Rating History for Entrada Therapeutics (TRDA) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for TRDA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/10/2026 Debjit Chattopadhyay New Coverage Buy
(N/A)		 20.00
(N/A)		 10.55
(12.58)		 19.24% Details